MedTrace Logo

Otoacoustic Emission Suppression Study

NCT04749524 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 236

Last updated 2024-08-16

Study results available
· View outcomes & findings →

Summary

The focus of this project is on a physiologic auditory response called the Medial Olivocochlear Reflex (MOCR) that assesses peripheral neural function. While neural hearing loss is a significant auditory disorder in patients of all ages, more than 50% of newborn infants are screened with a technology that is not sensitive to abnormalities in neural function. The development of a time-efficient and sensitive test system to assess the MOCR will provide significant benefit to infants and patients of all ages with neural deficits who would otherwise go undetected.

Conditions

  • Neonatal Hearing Loss

Interventions

DIAGNOSTIC_TEST

Medial-Olivocochlear Reflex (MOCR) Strength Measurement

Otoacoustic emissions (OAE) will be recorded using an ear probe with and without an efferent Medial-Olivocochlear Reflex (MOCR) elicitor.

Sponsors & Collaborators

  • National Institute on Deafness and Other Communication Disorders (NIDCD)

    collaborator NIH

  • Vanderbilt University

    collaborator OTHER

  • Intelligent Hearing Systems

    lead INDUSTRY

Principal Investigators

  • Linda J Hood, PHD · Vanderbilt University Medical School

  • Rafael E Delgado, PHD · Intelligent Hearing Systems Corp

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2023-06-23
Completion
2023-07-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04749524 on ClinicalTrials.gov